Physician profile
Torrey Healey
NPI 1770163750
$2,546.61
in general payments reported to CMS, 2019-2025
17 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $639 · 2023: $448 · 2024: $15.74 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052 · Travel and Lodging: $854 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.26 |
| Travel and Lodging | $853.96 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,365.93 | 2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $152.47 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $141.51 | 2022-2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $131.86 | 2022-2023 | Onpattro |
| Novo Nordisk INC | $128.02 | 2022-2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $117.23 | 2022-2023 | Xarelto |
| Amgen INC. | $100.16 | 2022-2023 | Repatha |
| Merck Sharp & Dohme LLC | $76.27 | 2022-2023 | Verquvo, Steglatro, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.44 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $52.84 | 2022-2023 | Brilinta, Farxiga |
| Esperion Therapeutics, INC. | $50.91 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.54 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $25.99 | 2023 | Arcalyst |
| Medtronic, INC. | $24.80 | 2025 | Symplicity G3 |
| Philips North America LLC | $23.76 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.30 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $18.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torrey Healey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.